Evidence map›Paper›PMID 35023410›Full record

ArticleWomen's health (London, England)

Overlapping needs for sexual and reproductive health and HIV prevention in women with substance use disorders.

Britton Gibson, Emily Hoff, Alissa Haas, Zoe M Adams, Carolina R Price, Dawn Goddard-Eckrich, Sangini S Sheth, Anindita Dasgupta, Jaimie P Meyer

Open access · goldAbstract read
In one paragraph

Article in Women's health (London, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Britton GibsonDepartment of Obstetrics and Gynecology, University of Connecticut, Farmington, CT, USA.ORCID 0000-0003-0058-4272
Emily HoffDepartment of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Alissa HaasIndiana University School of Medicine, Indianapolis, IN, USA.
Zoe M AdamsYale School of Medicine, New Haven, CT, USA.
Carolina R PriceAIDS Program, Yale School of Medicine, New Haven, CT, USA.
Dawn Goddard-EckrichSocial Intervention Group, Columbia University School of Social Work, New York, NY, USA.
Sangini S ShethDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-3154-9624
Anindita DasguptaSocial Intervention Group, Columbia University School of Social Work, New York, NY, USA.
Jaimie P MeyerAIDS Program, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5735-385X
Yale University · USColumbia University · USIndiana University School of MedicineUniversity of Connecticut · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
NIAAA Short-Term Training: Students in Health Professional SchoolsT35AA023760 · NIAAA · YALE UNIVERSITY · PI HERZOG, ERICA L, KRYSTAL, JOHN H. · 2017 to 2021
$314k
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS T35 AA023760NIDA NIH HHS T32 DA037801
6 · The paper itself

Abstract

objectivesWomen with substance use disorders have high unmet needs for HIV prevention and drug treatment and face challenges accessing care for other unique health issues, including their sexual and reproductive health.

methodsWe did a cross-sectional evaluation of sexual and reproductive health behaviors and outcomes among women with substance use disorders, who were enrolled in one of two concurrent clinical trials of pre-exposure prophylaxis for HIV prevention. Descriptive analyses and bivariate logistic regression were used to assess factors driving contraceptive use, and other essential sexual and reproductive health services utilization and outcomes.

resultsAmong 226 women, 173 (76.5%) were of reproductive age. Most women had histories of unintended pregnancy (79.2%) or miscarriage (45.1%) and high HIV risk behaviors (53.5%). Most (61%) participants did not use any form of contraception at the time of assessment, although few (15%) reported pregnancy intentions. In bivariate models, ongoing criminal justice involvement was associated with 2.22 higher odds of not using contraception (95% confidence interval = 1.09-4.53;

conclusionsThis is the first study that identifies the unmet sexual and reproductive health needs of women with substance use disorders who are engaging with pre-exposure prophylaxis. We found that women accessed some health services but not in a way that holistically addresses the full scope of their needs. Integrated sexual and reproductive care should align women's expressed sexual and reproductive health intentions with their behaviors and outcomes, by addressing social determinants of health.

Indexed as

HIV InfectionsSubstance-Related DisordersContraceptionContraception BehaviorCross-Sectional StudiesFemaleHumansPregnancyReproductive Healthhealth outcomesreproductive healthsubstance usewomen

Identifiers

PMID35023410
PMCPMC8771433
OpenAlexW4206701097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.